IPO Plans Sour on Both Sides of The Pond  

Oleh:

Mitchell, Peter

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: Nature Biotechnology: The Science and Business of Biotechnology vol. 22 no. 8 (Agu. 2004), page 929.
Topik: ipo; IPO plans; pond

Ketersediaan

Perpustakaan Pusat (Semanggi) Nomor Panggil: NN9.1 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

Several biotech companies on both sides of the atlantic had to cancel their initial public offerings (IPO) during the second quarter, because of lack of investor confidence. But companies that cannot wait to list because they are under pressure to provide an exit to their original investors have lowered their expectations and cut their pricing by up to 60% to float on the stock exchange. Some insiders predict the situation will not improve until after the US elections in november. On june 17, pulmonary and infectious disease drug developer CoTherix, S. San Fransisco, California, pulled out from its planned US$ 60 - 70 million IPO because of investor reluctance...

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali